ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 63 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $208 | -34.6% | 14,525 | -35.5% | 0.00% | – |
Q1 2024 | $318 | -33.6% | 22,517 | -29.0% | 0.00% | – |
Q4 2023 | $479 | +409.6% | 31,730 | +434.9% | 0.00% | – |
Q3 2023 | $94 | -3.1% | 5,932 | -7.9% | 0.00% | – |
Q2 2023 | $97 | -34.9% | 6,440 | -37.0% | 0.00% | – |
Q1 2023 | $149 | +2.1% | 10,228 | -5.1% | 0.00% | – |
Q4 2022 | $146 | -99.2% | 10,772 | +786.6% | 0.00% | – |
Q3 2022 | $19,000 | – | 1,215 | +3275.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 36 | -97.9% | 0.00% | – |
Q1 2022 | $16,000 | – | 1,709 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $75,769,000 | 16.37% |
5AM Venture Management, LLC | 4,408,379 | $75,471,000 | 14.16% |
72 Investment Holdings, LLC | 509,024 | $8,714,000 | 7.73% |
TCG Crossover Management, LLC | 663,694 | $11,362,000 | 5.32% |
Redmile Group, LLC | 1,954,420 | $33,460,000 | 0.76% |
StepStone Group LP | 761,277 | $13,033,000 | 0.74% |
Baker Brothers Advisors | 4,704,419 | $80,540,000 | 0.39% |
Avidity Partners Management LP | 255,000 | $4,366,000 | 0.09% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,798,000 | 0.04% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 106,000 | $1,815,000 | 0.04% |